Rankings
▼
Calendar
BCYC FY 2017 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$360M
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
-$10M
-476.0% margin
Operating Income
-$16M
-787.0% margin
Net Income
-$16M
-789.3% margin
EPS (Diluted)
$-1.22
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$3M
Stock-Based Comp.
$515,000
Balance Sheet
Total Assets
$74M
Total Liabilities
$121M
Stockholders' Equity
-$47M
Cash & Equivalents
$68M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$0
—
Gross Profit
-$10M
-$269,289
-3541.4%
Operating Income
-$16M
-$13M
-20.2%
Net Income
-$16M
-$14M
-20.3%
← FY 2016
All Quarters
Q4 2017 →